カテゴリ： MarketLine, アメリカ, 企業調査

AbbVie Inc.：企業の戦略・SWOT・財務情報

◆英語タイトル：AbbVie Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C15235
◆発行会社（調査会社）：MarketLine
◆発行日：2019年3月
◆ページ数：67
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

AbbVie Inc. – Strategy, SWOT and Corporate Finance Report
Summary

AbbVie Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

AbbVie Inc. (AbbVie or ‘the company’) is a biopharmaceutical company. The company offers pharmaceutical products that mainly consist of Humira (adalimumab) and products in therapeutic areas of oncology, metabolics/hormone, endocrinology, and virology. It offers products for people of every stage across infant, adolescent, adult and senior. The company also provides patient support programs and partners with biotechs, government organizations, and universities. AbbVie has manufacturing facilities in Ireland, the US, China, Singapore, Germany and in Italy. It also operates R&D centers in Germany, the US and Japan. The company operates in the US, Canada, Mexico, European Union, Japan, Brazil and other countries. The company is headquartered in North Chicago, Illinois, the US.

Scope

- Detailed information on AbbVie Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting AbbVie Inc. in the form of a SWOT analysis
- An in-depth view of the business model of AbbVie Inc. including a breakdown and examination of key business segments
- Intelligence on AbbVie Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about AbbVie Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of AbbVie Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess AbbVie Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on AbbVie Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
AbbVie Inc.: Company Overview
AbbVie Inc.: Overview and Key Facts
AbbVie Inc.: Overview
AbbVie Inc.: Key Facts
AbbVie Inc.: Key Employees
AbbVie Inc.: Key Employee Biographies
AbbVie Inc.: Major Products and Services
AbbVie Inc.: Company History
AbbVie Inc.: Management Statement
AbbVie Inc.: Locations and Subsidiaries
AbbVie Inc.: Key Competitors
AbbVie Inc.: Company Analysis
AbbVie Inc.: Business Description
AbbVie Inc.: SWOT Analysis
AbbVie Inc.: SWOT Overview
AbbVie Inc.: Strengths
AbbVie Inc.: Weaknesses
AbbVie Inc.: Opportunities
AbbVie Inc.: Threats
AbbVie Inc.: Corporate Financial Deals Activity
AbbVie Inc.: Financial Deals Overview
AbbVie Inc.: Targets and Partners
AbbVie Inc.: Top Deals 2015 – 2019YTD*
AbbVie Inc.: Advisors
AbbVie Inc.: Top Legal Advisors
AbbVie Inc.: Top Financial Advisors
AbbVie Inc.: Mergers and Acquisitions
AbbVie Inc.: Corporate Venturing
AbbVie Inc.: Capital Raising
AbbVie Inc.: Partnership
AbbVie Inc.: Recent Developments
AbbVie Inc.: News and Events Summary
AbbVie Inc.: Business Expansion
AbbVie Inc.: Contracts
AbbVie Inc.: Financial Deals
AbbVie Inc.: Market Developments
AbbVie Inc.: Regulatory and Legal Events
AbbVie Inc.: Research & Development
AbbVie Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: AbbVie Inc.: Key Facts
Table 2: AbbVie Inc.: Key Employees
Table 3: AbbVie Inc.: Company History
Table 4: AbbVie Inc.: Locations and Subsidiaries
Table 5: AbbVie Inc.: Key Competitors
Table 6: AbbVie Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: AbbVie Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: AbbVie Inc.: M&A Average Deal Size - Value (US$m)
Table 9: AbbVie Inc.: Targets and Partners
Table 10: AbbVie Inc.: Top Deals 2015 - 2019YTD*
Table 11: AbbVie Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: AbbVie Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: AbbVie Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: AbbVie Inc.: M&A Activity by Geography (2015 - YTD*2019)
Table 15: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 16: AbbVie Inc.: Corporate Venturing by Geography (2015 - YTD*2019)
Table 17: AbbVie Inc.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 18: AbbVie Inc.: Capital Raising by Deal Type (2015 - YTD*2019)
Table 19: AbbVie Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 20: AbbVie Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 21: AbbVie Inc.: News and Events Summary
Table 22: AbbVie Inc.: Business Expansion
Table 23: AbbVie Inc.: Contracts
Table 24: AbbVie Inc.: Financial Deals
Table 25: AbbVie Inc.: Market Developments
Table 26: AbbVie Inc.: Regulatory and Legal Events
Table 27: AbbVie Inc.: Research & Development
Table 28: AbbVie Inc.: Strategy and Operations

List of Figures
Figure 1: AbbVie Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: AbbVie Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: AbbVie Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: AbbVie Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 5: AbbVie Inc.: M&A Activity by Geography (2015 - YTD*2019)
Figure 6: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 7: AbbVie Inc.: Corporate Venturing by Geography (2015 - YTD*2019)
Figure 8: AbbVie Inc.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 9: AbbVie Inc.: Capital Raising by Deal Type (2015 - YTD*2019)
Figure 10: AbbVie Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 11: AbbVie Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)

★海外企業調査レポート[AbbVie Inc.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Ultrapar Participacoes SA (UGPA3)：企業の財務・戦略的SWOT分析
    Ultrapar Participacoes SA (UGPA3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Wilmar International Limited：企業の戦略・SWOT・財務情報
    Wilmar International Limited - Strategy, SWOT and Corporate Finance Report Summary Wilmar International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Prescient Therapeutics Ltd (PTX)-製薬・医療分野：企業M&A・提携分析
    Summary Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd is a clinical stage oncology company that develops novel drugs for the treatment of solid and hematological cancers. The company’s lead drug candidate includes PTX-200, a potent small molecule inhibitor of the A …
  • UnitedHealth Group Inc (UNH)-製薬・医療分野：企業M&A・提携分析
    Summary UnitedHealth Group Inc (UnitedHealth Group) is a diversified health care company. It offers health care services and products through two distinct platforms, namely UnitedHealthcare and Optum. Its UnitedHealthcare platform provides health care coverage and benefit services; and Optum platfor …
  • Chiyoda Corp (6366)：企業の財務・戦略的SWOT分析
    Chiyoda Corp (6366) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Intrexon Corp (XON)-医療機器分野：企業M&A・提携分析
    Summary Intrexon Corp (Intrexon), formerly Genomatix Corp is a provider of therapeutic solutions. The company operates through its divisions such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics division develops therap …
  • SiteOne Therapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary SiteOne Therapeutics Inc (SiteOne) is a biopharmaceutical company that develops novel non-opioid pain therapeutics for the treatment of acute and chronic pain. The company’s lead therapeutic candidates include ST-2427 Intravenous, for post-operative pain; ST-SubQ Subcutaneous and ST-Oral, fo …
  • Fastenal Co：戦略・SWOT・企業財務分析
    Fastenal Co - Strategy, SWOT and Corporate Finance Report Summary Fastenal Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Dubai Electricity and Water Authority：企業の発電所・SWOT分析2018
    Dubai Electricity and Water Authority - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Sinochem International Corp (600500)：企業の財務・戦略的SWOT分析
    Sinochem International Corp (600500) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Meridian Energy Limited：企業の戦略・SWOT・財務情報
    Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The Bank of New York Mellon Corporation：企業のM&A・事業提携・投資動向
    The Bank of New York Mellon Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Bank of New York Mellon Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed re …
  • Tosoh Bioscience Inc：企業の製品パイプライン分析2018
    Summary Tosoh Bioscience Inc (TBI), a subsidiary of Tosoh Corp, is a medical device company that offers diagnostic systems. The company provides analyzers, assays, immunoassay solutions, reagent technology, HbA1c solutions, ß-thalassemia testing, and HPLC technology. Its immunoassay solutions compri …
  • Cholamandalam Investment and Finance Company Ltd (CHOLAFIN)：企業の財務・戦略的SWOT分析
    Cholamandalam Investment and Finance Company Ltd (CHOLAFIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the comp …
  • China Banking Corporation：企業の戦略・SWOT・財務情報
    China Banking Corporation - Strategy, SWOT and Corporate Finance Report Summary China Banking Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ballard Power Systems Inc (BLDP)：電力：M&Aディール及び事業提携情報
    Summary Ballard Power Systems Inc (Ballard Power) is a clean energy growth company. It designs, develops, manufactures, sells, and services proton exchange membrane (PEM) fuel cell products for power product markets, portable power, and material handling and backup power. The company’s product lines …
  • Ann Inc：企業の戦略的SWOT分析
    Ann Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Fri-El Green Power SpA-エネルギー分野：企業M&A・提携分析
    Summary Fri-El Green Power SpA (Fri-El) is a renewable energy company that offers production of electric energy from renewable sources. The company develops, builds and manages power stations fuelled with biogas. Its wind energy is produced through wind turbine generators that convert wind to kineti …
  • BDO Unibank Inc：企業の戦略・SWOT・財務情報
    BDO Unibank Inc - Strategy, SWOT and Corporate Finance Report Summary BDO Unibank Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • NorgesGruppen ASA：企業の戦略的SWOT分析
    NorgesGruppen ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆